AIZ vs INO · P/E 15, rev $3.45B vs $88.0M cap
Assurant Inc (AIZ) versus Inovio Pharmaceuticals Inc (INO) — a side-by-side from cached financials, not a winner call.
Assurant Inc (AIZ) is a insurance - property & casualty company listed on US.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Latest reported AIZ revenue for 2026-06-30 was $3.45B. Net income was $298.6M. Revenue was up 1.0% from 2026-03-31 to 2026-06-30. AIZ currently screens at market cap $9.98B and trailing P/E 15.4.
Latest reported INO revenue for 2026-06-30 was $0. Net income was -$6.0M. INO currently screens at market cap $88.0M.
AIZ currently screens at market cap $9.98B and trailing P/E 15.4. INO currently screens at market cap $88.0M.
Not investment advice. Open the AIZ and INO stock pages for the full models.
Not investment advice.